Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aegerion Pharmaceuticals Inc (NASDAQ:AEGR)

1.53
Delayed Data
As of 2:35pm ET
 +0.06 / +4.08%
Today’s Change
1.23
Today|||52-Week Range
20.45
-84.85%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues64.2M67.3M49.0M35.7M
 
 
 
 
 
Cost of Goods Sold8.7M8.9M6.5M9.4M
 
 
 
 
 
Depreciation And Amortization5.3M5.6M5.5M5.5M
 
 
 
 
 
 
Operating ExpensesGross Income50.2M52.8M37.0M20.8M
 
 
 
 
 
General Expenses55.1M55.2M65.7M49.6M
 
 
 
 
 
Research And Development12.5M11.3M11.3M9.9M
 
 
 
 
 
Total Operating Expenses69.1M69.7M77.7M64.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.9M-2.4M-28.7M-28.8M
 
 
 
 
 
Extraordinary Charge0.000.00---30.0M
 
 
Interest Expense On Debt7.1M7.1M6.5M7.2M
 
 
 
 
 
Other Expenses1.1M30.0K-410.0K738.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-10.9M-9.5M-35.6M-65.3M
 
 
 
 
 
Income Taxes-254.0K-294.0K-1.0M-257.0K
 
 
 
 
 
Net Income-11.2M-9.8M-36.6M-65.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS28.6M28.7M29.1M29.5M
 
 
 
 
 
Shares To Calculate EPS Diluted28.6M28.7M29.1M29.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.39-$0.34-$1.26-$2.22
 
 
 
 
 
EPS Diluted-$0.39-$0.34-$1.26-$2.22